1. Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics
   Zhengyun Liu et al, 2021, Scientific Reports CrossRef
2. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines
   Pablo García-Molina et al, 2022, Pharmaceutics CrossRef
3. MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A
   Yizhou Wang et al, 2018, Pathology - Research and Practice CrossRef